Qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 in cervical secretions during pregnancy
- UID
- IMP/IVD/2019/000211_d2754a71db42c52ac7b79983121d6d14_5344cd63d36fd02154e71a64ee072263
- Device class
- Class B
- Brand name
- Actim Prom
- License holder
- Advy Chemical Private Limited
- Approving authority
- CDSCO
- Product information
- Actim® Partus test is a visually interpreted, qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 (Actim Prom) in cervical secretions during pregnancy. The test is intended for professional use to help predict the risk of preterm or imminent delivery when fetal membranes are intact.
Qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 in cervical secretions during pregnancy is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000211_d2754a71db42c52ac7b79983121d6d14_5344cd63d36fd02154e71a64ee072263. This device is marketed under the brand name Actim Prom. The license holder is Advy Chemical Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.